(Q34112649)

31 July 2017

1 reference

title

Combination drugs for treating obesity (English)

1 reference

31 July 2017

0 references

2

George A Bray

1 reference

31 July 2017

1

Frank L Greenway

1 reference

31 July 2017

1 April 2010

1 reference

31 July 2017

Current diabetes report

1 reference

31 July 2017

10

1 reference

31 July 2017

2

1 reference

31 July 2017

108-115

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-010-0096-4

31 July 2017

0 references

cites work

Treatment of hypothalamic obesity with caffeine and ephedrine

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0096-4

Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0096-4

Pharmaceutical cost savings of treating obesity with weight loss medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0096-4

Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0096-4

Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0096-4

Meta-analysis: pharmacologic treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0096-4

Rational design of a combination medication for the treatment of obesity

21 January 2018

1 reference

12 December 2020

The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent

1 reference

12 December 2020

Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy

1 reference

12 December 2020

The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial

1 reference

12 December 2020

A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination

1 reference

12 December 2020

Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo

1 reference

12 December 2020

Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study

1 reference

12 December 2020

Clinical studies with phenylpropanolamine: a metaanalysis

1 reference

12 December 2020

The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome

1 reference

12 December 2020

Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity

1 reference

12 December 2020

The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study

1 reference

12 December 2020

Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women

1 reference

12 December 2020

Ephedrine as an anorectic: the story of the 'Elsinore pill'

1 reference

12 December 2020

Long-term drug treatment of obesity in a private practice setting

1 reference

12 December 2020

Does ephedrine promote weight loss in low-energy-adapted obese women?

1 reference

12 December 2020

A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity

1 reference

12 December 2020

Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies

1 reference

12 December 2020

Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis

1 reference

12 December 2020

Treatment of obesity with "combination" pharmacotherapy

1 reference

12 December 2020

Zonisamide for weight loss in obese adults: a randomized controlled trial

1 reference

12 December 2020

Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study

1 reference

12 December 2020

Valvular heart disease associated with fenfluramine-phentermine

1 reference

12 December 2020

Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial

1 reference

12 December 2020

The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress

1 reference

12 December 2020

Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms

1 reference

12 December 2020

Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials

1 reference

12 December 2020

Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.

1 reference

12 December 2020

Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study.

1 reference

12 December 2020

Health implications of obesity. National Institutes of Health Consensus Development Conference Statement

1 reference

12 December 2020

Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus

1 reference

12 December 2020

Obesity is a chronic, relapsing neurochemical disease

1 reference

12 December 2020

National trends in antiobesity medication use.

1 reference

12 December 2020

High-dose naltrexone therapy and dietary counseling for obesity

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

How physician obesity specialists use drugs to treat obesity

1 reference

12 December 2020

Phenylpropanolamine and the risk of hemorrhagic stroke

1 reference

12 December 2020

Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.

1 reference

12 December 2020

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

1 reference

12 December 2020

Comparison of the effect of orlistat vs orlistat plus metformin on weight loss and insulin resistance in obese women

1 reference

12 December 2020

10.1007/S11892-010-0096-4

Identifiers

DOI

1 reference

PubMed ID

20425569

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

20425569